Hydroxy Compound Active Ingredients TRIZ Cases
- Phytocannabinoid Transdermal Formulation for Sustained Skin Delivery
This case combines penetration enhancers, thickening agents, and microencapsulated cannabidiol to improve sustained skin delivery.
- Hypoxia-Activated Therapy for Solid Tumors with Checkpoint Blockade
This case combines HABA, induced tumor hypoxia, and immune checkpoint inhibitors to promote tumor necrosis and stronger anti-tumor immunity.
- Liposoluble Active Ingredient Nanocapsules for Oxidation Stability
This case uses ionic surfactants and polymers to stabilize liposoluble actives, supporting bioavailability during storage and digestion.
- Chlorogenic Acid Oral Composition with 4-Vinylguaiacol for Balanced Sourness
A defined 4-vinylguaiacol ratio helps preserve sourness while improving taste quality in high-chlorogenic-acid, caffeine oral compositions.
- Osteogenic Compound Compositions for Bone Formation and Remodeling
This case uses osteogenic compounds to stimulate osteoblast differentiation and promote bone formation beyond antiresorptive suppression.
- SLC28A3 Transporter Inhibition for Anthracycline Cardiotoxicity
Blocking SLC28A3 can protect cardiomyocytes from anthracycline uptake while supporting higher cumulative chemotherapy doses.